Nov, 01 2023

Thermo Fisher Scientific Inc., F. Hoffmann-La Roche Ltd, and Biocartis are Dominating the Europe Kirsten Rat Sarcoma (KRAS) Market in 2020

Europe Kirsten Rat Sarcoma (KRAS) Market is expected to grow with the CAGR of 11.8% in the forecast period of 2021 to 2028. The years considered for study are as mentioned below.

Access Full Report @ https://www.databridgemarketresearch.com/fr/reports/europe-kirsten-rat-sarcoma-kras-market

Europe Kirsten Rat Sarcoma (KRAS) Market is a highly consolidated market, which includes specific number of key players as well as local players. The market has witnessed increased strategic developments owing to favourable market scenario.

The major players dealing in Kirsten Rat Sarcoma (KRAS) market are introducing strong range of product portfolio. This helped companies to maximize the sales with enhanced product portfolio.

For instance,

In October 2018, Ilumina Inc had launched the True Sight Oncology 500. The liquid biopsy panel, is a comprehensive pan-cancer assay, which has been designed to identify and detect known and upcoming tumor biomarkers. The panel launched by the company were used for molecular testing of biomarkers in lung cancer, being implemented for precision oncology and strengthened the Oncology portfolio. It demonstrated a positive growth in the market.

Thermo Fisher Scientific Inc., is dominating player in Kirsten Rat Sarcoma (KRAS) market. The other key players existing in the market includes F. Hoffmann-La Roche Ltd, Biocartis, Illumina, Inc., Merck KGaA, Abbott, QIAGEN, Agilent Technologies, Inc., among others.

Thermo Fisher Scientific Inc.

Thermo Fisher Scientific Inc., headquartered in Massachusetts, U.S. was founded in 2006. The company engages in the development, manufacture, marketing and sale of medical devices. The company offers Laboratory Supplies, Laboratory Equipment, Laboratory Instruments, Clinical & Diagnostics, Chromatography & Mass Spectrometry, Cell Culture, Protein and Cell Analysis, Molecular Biology & Nucleic Acid Analysis, Sequence-Specific Nucleic Acid Products. The company has presence in North America, Europe, and Asia-Pacific. The company has various subsidiaries that are Smith & Nephew Argentina S.R.L.2 (Argentina), Smith & Nephew Pty Limited (Australia), Smith & Nephew Medical (Shanghai) Limited (China), Smith & Nephew S.A. de C.V. (Mexico), Smith & Nephew Limited1 (New Zealand) among others.

For instance,

In October 2020, Thermo Fischer Scientific Inc, had announced to extend its collaboration with Symphogen, to provide nnovative cancer treatments through optimization of protein characterization and quality monitoring mass spectrometry workflows. The companies can provide the biopharmaceutical industry with compliance ready mass spectrometer solutions to boost the drug delivery. It would deliver a positive growth in the market.

F. Hoffman-La Roche Ltd.

F. Hoffman La Roche Ltd. headquartered in Basel, Switzerland and was founded in year 1886. The company is focused on development of innovative medicines and diagnostics tests that help patients live longer and better lives. The company offers Blood Safety, Clinical Chemistry & Immunochemistry, Companion Diagnostics, Custom Biotech, Diabetes Care, Lab Automation & Software Solution, Molecular Diagnostics, Point of Care, and Tissue Diagnostics. The company has wide global presence across the world as North America, Europe, Asia-Pacific, South America, Middle East and Africa. Genentech (U.S), Chugai Pharmaceutical Co. (Japan), ROCHE HOLDING (UK) LIMITED (UK), Roche (Philippines) Inc. (Philippines), Roche Chile Limitada (Chile) among others are the subsidiaries of the company.

For instance,

In November 2015, F. Hoffmann-La Roche Ltd announced that they had expanded molecular diagnostic assays by Cobas 4800. This system will improve the efficiency and flexibility that allows laboratories to deliver results for rapid clinical decisions. This has increase the demand for the product in the recent past and is expected to increase in the forecasted period.

Biocartis

Biocartis is headquartered in Mechelen, Belgium and was founded in 2007. The company is focused to offer rapid & easy molecular diagnostics solutions aimed on fast and accurate treatment decisions for oncology patients across the globe. The company offers products for Infectious Disease, Oncology, and Pharma. The company has wide global presence across Americas, Europe, Asia-Pacific, Middle East and Africa. The company has various subsidiaries such as Biocartis NV (Belgium), Biocartis US Inc. (U.S.) and others.

For instance,

In December 2017, Biocartis announced that they had signed the agreement with Amgen to develop a platform for CDx for colorectal cancer. Under this, the Idylla platform is being used to develop test for the drug and help Amgen bring this product in the market and synergistically contribute to Biocartis growth in the forecast period.

CHOOSE LICENCE TYPE

Enterprise User 7000
Single User 4800
DBMR Factbook 3000
DBMR Prime 8000
DBMR Supreme 12000

Buy Now

Advance Formative Research Customization Request for bulk Reports

Latest Press Release

Growth in Offshore Oil and Gas Activities is driving the Growth of the U.S Ship Repair and Maintenance Services Market

Rising Prevalence of Genetic Disorders is Driving the Growth of the Global Multiple Hereditary Exostosis Market

Growing Industrialization Fuels Lubricant Usage in Machinery and Equipment is Expected to Drive the Growth for the U.S. Lubricants Market

Rising Demand for Quality Control is Driving the Growth of the Global Industrial Metrology Market

Increasing Prevalence Of Hepatitis B Infections Drives the Growth of Global Hepatitis B Treatment Market

VIEW ALL

Client Testimonials

David Manning - Thermo Fisher Scientific

Director, Global Strategic Accounts,

Dear Ricky,
I want to thank you for the excellent market analysis (LIMS INSTALLED BASE DATA) that you and your team delivered, especially end of year on short notice. Sachin and Shraddha captured the requirements, determined their path forward and executed quickly.
You, Sachin and Shraddha have been a pleasure to work with – very responsive, professional and thorough. Your work is much appreciated.

Manager - Market Analytics,

Uriah D. Avila - Zeus Polymer Solutions

Thank you for all the assistance and the level of detail in the market report. We are very pleased with the results and the customization. We would like to continue to do business.

Business Development Manager,

(Pharmaceuticals Partner for Nasal Sprays) | Renaissance Lakewood LLC

DBMR was attentive and engaged while discussing the Global Nasal Spray Market. They understood what we were looking for and was able to provide some examples from the report as requested. DBMR Service team has been responsive as needed. Depending on what my colleagues were looking for, I will recommend your services and would be happy to stay connected in case we can utilize your research in the future.

Business Intelligence and Analytics,

Ipsen Biopharm Limited

We are impressed by the CENTRAL PRECOCIOUS PUBERTY (CPP) TREATMENT report - so a BIG thanks to you colleagues.

Competition Analyst,

Basler Web

I just wanted to share a quick note and let you know that you guys did a really good job. I’m glad I decided to work with you. I shall continue being associated with your company as long as we have market intelligence needs.

Marketing Director,

Buhler Group

It was indeed a good experience, would definitely recommend and come back for future prospects.

COO,

A global leader providing Drug Delivery Services

DBMR did an outstanding job on the Global Drug Delivery project, We were extremely impressed by the simple but comprehensive presentation of the study and the quality of work done. This report really helped us to access untapped opportunities across the globe.

Marketing Director,

Philips Healthcare

The study was customized to our targets and needs with well-defined milestones. We were impressed by the in-depth customization and inclusion of not only major but also minor players across the globe. The DBMR Market position grid helped us to analyze the market in different dimension which was very helpful for the team to get into the minute details.

Product manager,

Fujifilms

Thankful to the team for the amazing coordination, and helping me at the last moment with my presentation. It was indeed a comprehensive report that gave us revenue impacting solution enabling us to plan the right move.

Investor relations,

GE Healthcare

Thank you for the report, and addressing our needs in such short time. DBMR has outdone themselves in this project with such short timeframe.

Market Analyst,

Medincell

We found the results of this study compelling and will help our organization validate a market we are considering to enter. Thank you for a job well done.

Andrew - Senior Global Marketing Manager,

Medtronic (US)

I want to thank you for your help with this report – It’s been very helpful in our business planning and it well organized.

Amarildo - Manager, Global Strategic Alignment

MasterCard

We believe the work done by Data Bridge Team for our requirements in the North America Loyalty Management Market was fantastic and would love to continue working with your team moving forward.

Tor Hammer

Green Nexus LLc

Thank you for your quick response to this unfortunate circumstance. Please extend my thanks to your reach team. I will be contacting you in the future with further projects

Tommaso Finocchiaro

Market Intelligence Specialist Nippon Gasses

I acknowledge the difficulty given by the very short warning for this report, and I think that its quality and your delivering time have been very satisfying. Obviously, as a provider Data Bridge Market Research will be considered as a plus for future needs of Nippon Gases.

Yuki Kopyl (Asian Business Development Department)

UENO FOOD TECHNO INDUSTRY, LTD. (JAPAN)

Xylose report was very useful for our team. Thank you very much & hope to work with you again in the future

Press Release